Work

FOXM1 cistrome predicts breast cancer metastatic outcome better than FOXM1 expression levels or tumor proliferation index

Year: 2015

Type: article

Source: Breast Cancer Research and Treatment

DOI: 10.1007/s10549-015-3589-7

Authors: Christina Yau, Laurence Meyer, Stephen Benz, Charles Vaske, Gary Scott, Brian Egan, Paul Labhart, Nader Pourmand, Christopher C. Benz

Institutions: Buck Institute for Research on Aging, University of California, Santa Cruz, NantOmics LLC (United States), Active Motif (United States), University of California, San Francisco

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Sanofi, California Breast Cancer Research Program, Buck Institute for Research on Aging, National Institutes of Health, National Human Genome Research Institute, National Cancer Institute

Awards: G1083213090, G3760688834, G5917059840, G9000086836, G9000340741

OpenAlex ID: W1916445744

FWCI: 0.689

Cites: 13

Cited by: 11

Related to: 10